Biology and technology are accelerating the green transition. The merger of Novozymes and Chr. Hansen has created Novonesis, a global leader in what the new company calls “biosolutions.”
Combining expertise, talent and research and development, today Novonesis delivers innovations and sustainable solutions in food, health and the environment.
With increasing demand for biosolutions across the Asia-Pacific, last year saw Novonesis report 10% organic growth in the region.
“The combination of two extraordinary companies makes us better, stronger and more well equipped to develop solutions for today, and for the future,” said Lensey Chen, regional president of Novonesis APAC.
Biosolutions already play an important role in our daily lives by supporting gut health, lessening reliance on artificial additives, reducing sugar in yogurt, enhancing the taste of plant-based foods and improving food freshness.
“Food moves from farm to table through vast, interwoven food systems and a change, no matter in which area, ripples through the entire supply chain,” Chen said.
“Our advanced solutions help rethink every step of the food value chain, from soil health to food preservation.”
Agents of change
They are also making the detergents we use more effective and helping to reduce our reliance on fossil fuels through biofuels.
“While Novonesis’ biosolutions cannot be seen with the naked eye, we are taking care of people and improving society,” Chen said.
“As our solutions improve our daily lives, we will continue to do more in the future.”
Novonesis APAC leads the world in biotechnology and patent activity, and governments across the region are investing in biosolutions to build a more sustainable future.
Innovative solutions for Japan
Japan is one of Novonesis’ largest markets in the region and the company has been active in the Japanese market since 1977.
Japan’s annually updated bio-strategy began in 2019 and reflects the country’s commitment to biotechnologies. Novonesis is expanding its capabilities to meet demand.
Novonesis’ R&D facility in Chiba Prefecture was the company’s first outside of Denmark and 2022 saw Novonesis celebrate 40 years of R&D in Japan and 30 years of funding Japanese academic research.
With Japan aiming to become the world’s most advanced biotech economy by 2030, Novonesis is shaping the future of global biosolutions, hand in hand with Japan.
Japan is set to remain a trusted partner as Novonesis continues to support sustainable food systems and deliver health solutions in line with the green transition.
